1. Duong, Connie, Yoshida, Sakiko, Chen, Cathy, Nitin, Nitin, Satake, Noriko. 2017. Novel targeted therapy for neuroblastoma: silencing the MXD3 gene using siRNA. In Pediatric research, 82, 527-535. doi:10.1038/pr.2017.74. https://pubmed.ncbi.nlm.nih.gov/28419087/
2. Xia, Haoran, Wang, Miaomiao, Su, Xiaonan, Guo, Xiaoxiao, Liu, Ming. 2022. A Novel Gene Signature Associated With "E2F Target" Pathway for Predicting the Prognosis of Prostate Cancer. In Frontiers in molecular biosciences, 9, 838654. doi:10.3389/fmolb.2022.838654. https://pubmed.ncbi.nlm.nih.gov/35495629/
3. Zhang, Fangyuan, Liu, Liansheng, Wu, Pengjie, Li, Shengwen, Wei, Dong. . Overexpression of MAX dimerization protein 3 (MXD3) predicts poor prognosis in clear cell renal cell carcinoma. In Translational andrology and urology, 10, 785-796. doi:10.21037/tau-20-1187. https://pubmed.ncbi.nlm.nih.gov/33718080/